Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

Andras Heczey(Baylor College of Medicine), Amy N. Courtney(Baylor College of Medicine), Antonino Montalbano(Immunai (United States)), Simon N. Robinson(Baylor College of Medicine), Liu Ka(Baylor College of Medicine), Mingmei Li(Baylor College of Medicine), Nisha Ghatwai(Baylor College of Medicine), Olga Dakhova(Baylor College of Medicine), Bin Liu(Baylor College of Medicine), Tali Raveh-Sadka(Immunai (United States)), Cynthia Chauvin(Baylor College of Medicine), Xin Xu(Baylor College of Medicine), Ho Ngai(Baylor College of Medicine), Erica J. Di Pierro(Baylor College of Medicine), Barbara Savoldo(University of North Carolina at Chapel Hill), Gianpietro Dotti(University of North Carolina at Chapel Hill), Leonid S. Metelitsa(Baylor College of Medicine)
Nature Medicine
October 12, 2020
10.1038/s41591-020-1074-2
Cited by 272

Abstract

Related Papers

Fast gapped-read alignment with Bowtie 2
Ben Langmead, Steven L. Salzberg|Nature Methods|2012|60.7k
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy, Jeffrey W. Pollard|Immunity|2014|4k
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn, Andrew D.J. Pearson, Wendy B. London et al.|Journal of Clinical Oncology|2008|1.9k
NKT cells: what's in a name?
Dale I. Godfrey, H. Robson MacDonald, Mitchell Kronenberg et al.|Nature reviews. Immunology|2004|1.2k
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 <b>+</b> T cells
Luca Gattinoni, Steven E. Finkelstein, Christopher A. Klebanoff et al.|The Journal of Experimental Medicine|2005|1k